Advanced search
Publication Cover
International Journal of Chronic Obstructive Pulmonary Disease Volume 16, 2021 - Issue
Submit an article Journal homepage
294
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Anxiety and Depression in Patients with Chronic Obstructive Pulmonary Disease in China: Results from the China Pulmonary Health [CPH] Study

Ke Huang1 Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, People’s Republic of China;2 Department of Pulmonary and Critical Care Medicine, National Clinical Research Center for Respiratory Diseases, Beijing, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0001-8933-387X
ORCID Icon,
Kewu Huang3 Beijing Key Laboratory of Respiratory and Pulmonary Circulation Disorders, Department of Pulmonary and Critical Care Medicine, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, People’s Republic of China
,
Jianying Xu4 Department of Pulmonary and Critical Care Medicine, Shanxi Dayi Hospital, Taiyuan, People’s Republic of China
,
Lan Yang5 Department of Pulmonary and Critical Care Medicine, First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, People’s Republic of China
,
Jianping Zhao6 Department of Pulmonary and Critical Care Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People’s Republic of China
,
Xiangyan Zhang7 Department of Pulmonary and Critical Care Medicine, Guizhou Provincial People’s Hospital, Guiyang, People’s Republic of China
,
Chunxue Bai8 Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0002-0119-8990
ORCID Icon,
Jian Kang9 Department of Pulmonary and Critical Care Medicine, First Hospital of China Medical University, Shenyang, People’s Republic of China
,
Pixin Ran10 State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Diseases, Guangzhou Institute of Respiratory Diseases, First Affiliated Hospital, Guangzhou Medical University, Guangzhou, People’s Republic of China
,
Huahao Shen11 Department of Respiratory and Critical Care Medicine, Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, People’s Republic of China
,
Fuqiang Wen12 State Key Laboratory of Biotherapy of China and Department of Respiratory and Critical Care Medicine, West China Hospital of Sichuan University, Chengdu, People’s Republic of China
,
Yahong Chen13 Department of Respiratory and Critical Care Medicine, Peking University Third Hospital, Beijing, People’s Republic of China
,
Tieying Sun14 Department of Respiratory and Critical Care Medicine, Beijing Hospital, Beijing, People’s Republic of China
,
Guangliang Shan15 Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, School of Basic Medicine, Peking Union Medical College, Beijing, People’s Republic of China
,
Yingxiang Lin3 Beijing Key Laboratory of Respiratory and Pulmonary Circulation Disorders, Department of Pulmonary and Critical Care Medicine, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, People’s Republic of China
,
Sinan Wu2 Department of Pulmonary and Critical Care Medicine, National Clinical Research Center for Respiratory Diseases, Beijing, People’s Republic of China;16 Institute of Clinical Medical Sciences, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, People’s Republic of China
,
Ting Yang1 Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, People’s Republic of China;2 Department of Pulmonary and Critical Care Medicine, National Clinical Research Center for Respiratory Diseases, Beijing, People’s Republic of China;17 Department of Respiratory Medicine, Capital Medical University, Beijing, People’s Republic of China
&
Chen Wang1 Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, People’s Republic of China;2 Department of Pulmonary and Critical Care Medicine, National Clinical Research Center for Respiratory Diseases, Beijing, People’s Republic of China;17 Department of Respiratory Medicine, Capital Medical University, Beijing, People’s Republic of China;18 Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, People’s Republic of ChinaCorrespondence[email protected] [email protected]
ORCID Iconhttps://orcid.org/0000-0001-7857-5435
ORCID Icon show all
Pages 3387-3396 | Published online: 17 Dec 2021

Figures & data

Table 1 Characteristics of All Participants with Anxiety and Depression

Figure 1 Prevalence of anxiety and depression in populations with COPD and non-COPD. The HADS subscale scores were used to define the severity of anxiety or depression, with a score of 8–10 denoting mild case, 11–14 moderate case and 15 or higher severe case.

Abbreviation: COPD, chronic obstructive pulmonary disease.
Figure 1 Prevalence of anxiety and depression in populations with COPD and non-COPD. The HADS subscale scores were used to define the severity of anxiety or depression, with a score of 8–10 denoting mild case, 11–14 moderate case and 15 or higher severe case.

Figure 2 Prevalence of anxiety and depression in patients with different stages of COPD. The HADS subscale scores were used to define the severity of anxiety or depression, with a score of 8–10 denoting mild case, 11–14 moderate case and 15 or higher severe case.

Abbreviations: COPD, chronic obstructive pulmonary disease; GOLD, Global Initiative for Chronic Obstructive Lung Disease.
Figure 2 Prevalence of anxiety and depression in patients with different stages of COPD. The HADS subscale scores were used to define the severity of anxiety or depression, with a score of 8–10 denoting mild case, 11–14 moderate case and 15 or higher severe case.

Figure 3 Coincidence of anxiety and depression in populations with COPD and non-COPD. This figure show the prevalence of subjects suffered from anxiety and depression concomitantly in COPD and non-COPD groups, as well as different GOLD stage groups.

Abbreviations: COPD, chronic obstructive pulmonary disease; GOLD, Global Initiative for Chronic Obstructive Lung Disease.
Figure 3 Coincidence of anxiety and depression in populations with COPD and non-COPD. This figure show the prevalence of subjects suffered from anxiety and depression concomitantly in COPD and non-COPD groups, as well as different GOLD stage groups.

Table 2 Multivariate Logistic Regression for Effect of COPD and Lung Function on Anxiety or Depression

Table 3 Multivariate Logistic Regression for Effect of COPD and Lung Function on Anxiety and Depression

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.